VWF antigen/ADAMTS13 ratio has a significant prognostic power at different time points after heart attacks concomitant with higher chances of adverse outcomes in clinical practise, like heart failure and thrombosis [23]. The gene discussed is ADAMTS13; the disease is Venous thrombosis.